Exogenous nitric oxide regulates cyclooxygenase-2 expression and prostaglandin D2 generation through p38 MAPK in mouse bone marrow-derived mast cells

Free Radical Biology and Medicine

Volumn 45, Issue 6, 2008, Pages 780-788

  Moon, Tae Chul ^a   Befus, A Dean ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; Interleukin 6; Lipid mediators; Mast cells; Nitric oxide; Prostaglandin D2

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOOXYGENASE 2; GUANYLATE CYCLASE INHIBITOR; HEMOGLOBIN; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NITRIC OXIDE DONOR; PROSTAGLANDIN D2; STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; INFLAMMATION; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RNA STABILITY; SENSITIZATION;

ANIMALS; BLOTTING, WESTERN; BONE MARROW; CYCLOOXYGENASE 2; ELECTROPHORESIS, POLYACRYLAMIDE GEL; INTERLEUKIN-6; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTAGLANDIN D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 54949139206     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.06.005     Document Type: Article

References (72)

1. Vliagoftis H., and Befus A.D. Mast cells at mucosal frontiers. Curr. Mol. Med. 5 (2005) 573-589
2. Marshall J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4 (2004) 787-799
3. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6 (2005) 135-142
4. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23 (2005) 749-786
5. Bruckdorfer R. The basics about nitric oxide. Mol. Aspects Med. 26 (2005) 3-31
6. Bove P.F., and van der Vliet A. Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radic. Biol. Med. 41 (2006) 515-527
7. Mannaioni P.F., Masini E., Pistelli A., Salvemini D., and Vane J.R. Rat mast cells inhibit platelet aggregation by releasing a nitric oxide-like factor: influence of histamine release. Agents Actions Suppl. 33 (1991) 423-428
8. Eastmond N.C., Banks E.M., and Coleman J.W. Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-gamma-induced suppression of exocytosis. J. Immunol. 159 (1997) 1444-1450
9. Coleman J.W. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin. Exp. Immunol. 129 (2002) 4-10
10. Gilchrist M., McCauley S.D., and Befus A.D. Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood 104 (2004) 462-469
11. Davis B.J., Flanagan B.F., Gilfillan A.M., Metcalfe D.D., and Coleman J.W. Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells. J. Immunol. 173 (2004) 6914-6920
12. Forsythe P., and Befus A.D. Inhibition of calpain is a component of nitric oxide-induced down-regulation of human mast cell adhesion. J. Immunol. 170 (2003) 287-293
13. Sekar Y., Moon T.C., Munoz S., and Befus A.D. Role of nitric oxide in mast cells: controversies, current knowledge, and future applications. Immunol. Res. 33 (2005) 223-239
14. Nohara O., Kulka M., Dery R.E., Wills F.L., Hirji N.S., Gilchrist M., and Befus A.D. Regulation of CD8 expression in mast cells by exogenous or endogenous nitric oxide. J. Immunol. 167 (2001) 5935-5939
15. Kitajima I., Kawahara K., Nakajima T., Soejima Y., Matsuyama T., and Maruyama I. Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem. Biophys. Res. Commun. 204 (1994) 244-251
16. Bissonnette E.Y., Hogaboam C.M., Wallace J.L., and Befus A.D. Potentiation of tumor necrosis factor-alpha-mediated cytotoxicity of mast cells by their production of nitric oxide. J. Immunol. 147 (1991) 3060-3065
17. Matsuoka T., Hirata M., Tanaka H., Takahashi Y., Murata T., Kabashima K., Sugimoto Y., Kobayashi T., Ushikubi F., Aze Y., Eguchi N., Urade Y., Yoshida N., Kimura K., Mizoguchi A., Honda Y., Nagai H., and Narumiya S. Prostaglandin D2 as a mediator of allergic asthma. Science 287 (2000) 2013-2017
18. Bochenek G., Nizankowska E., Gielicz A., Swierczynska M., and Szczeklik A. Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 59 (2004) 459-464
19. Boyce J.A. Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. Chem. Immunol. Allergy 87 (2005) 59-79
20. Hirai H., Tanaka K., Yoshie O., Ogawa K., Kenmotsu K., Takamori Y., Ichimasa M., Sugamura K., Nakamura M., Takano S., and Nagata K. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193 (2001) 255-261
21. Murakami M., Matsumoto R., Austen K.F., and Arm J.P. Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells. J. Biol. Chem. 269 (1994) 22269-22275
22. Moon T.C., Murakami M., Ashraf M.D., Kudo I., and Chang H.W. Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and Fc epsilon receptor I crosslinking in cultured mast cells. Cell. Immunol. 185 (1998) 146-152
23. Diaz B.L., Fujishima H., Kanaoka Y., Urade Y., and Arm J.P. Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow-derived mast cells by exogenous but not endogenous prostanoids. J. Immunol. 168 (2002) 1397-1404
24. Murakami M., Bingham III C.O., Matsumoto R., Austen K.F., and Arm J.P. IgE-dependent activation of cytokine-primed mouse cultured mast cells induces a delayed phase of prostaglandin D2 generation via prostaglandin endoperoxide synthase-2. J. Immunol. 155 (1995) 4445-4453
25. Ashraf M., Murakami M., and Kudo I. Cross-linking of the high-affinity IgE receptor induces the expression of cyclo-oxygenase 2 and attendant prostaglandin generation requiring interleukin 10 and interleukin 1 beta in mouse cultured mast cells. Biochem. J. 320 Pt 3 (1996) 965-973
26. Mollace V., Muscoli C., Masini E., Cuzzocrea S., and Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol. Rev. 57 (2005) 217-252
27. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl Acad. Sci. USA 90 (1993) 7240-7244
28. Salvemini D., and Masferrer J.L. Interactions of nitric oxide with cyclooxygenase: in vitro, ex vivo, and in vivo studies. Methods Enzymol. 269 (1996) 12-25
29. Kim S.F., Huri D.A., and Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310 (2005) 1966-1970
30. Morioka N., Inoue A., Hanada T., Kumagai K., Takeda K., Ikoma K., Hide I., Tamura Y., Shiomi H., Dohi T., and Nakata Y. Nitric oxide synergistically potentiates interleukin-1 beta-induced increase of cyclooxygenase-2 mRNA levels, resulting in the facilitation of substance P release from primary afferent neurons: involvement of cGMP-independent mechanisms. Neuropharmacology 43 (2002) 868-876
31. Yang T., Zhang A., Pasumarthy A., Zhang L., Warnock Z., and Schnermann J.B. Nitric oxide stimulates COX-2 expression in cultured collecting duct cells through MAP kinases and superoxide but not cGMP. Am. J. Physiol. Renal Physiol. 291 (2006) F891-F895
32. Cheng H.F., Zhang M.Z., and Harris R.C. Nitric oxide stimulates cyclooxygenase-2 in cultured cTAL cells through a p38-dependent pathway. Am. J. Physiol. Renal Physiol. 290 (2006) F1391-F1397
33. Doni M.G., Whittle B.J., Palmer R.M., and Moncada S. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur. J. Pharmacol. 151 (1988) 19-25
34. Stadler J., Harbrecht B.G., Di Silvio M., Curran R.D., Jordan M.L., Simmons R.L., and Billiar T.R. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J. Leukoc. Biol. 53 (1993) 165-172
35. Swierkosz T.A., Mitchell J.A., Warner T.D., Botting R.M., and Vane J.R. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br. J. Pharmacol. 114 (1995) 1335-1342
36. Clancy R., Varenika B., Huang W., Ballou L., Attur M., Amin A.R., and Abramson S.B. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J. Immunol. 165 (2000) 1582-1587
37. Cuzzocrea S., and Salvemini D. Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes. Kidney Int. 71 (2007) 290-297
38. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
39. He X., Azarov I., Jeffers A., Presley T., Richardson J., King S.B., Gladwin M.T., and Kim-Shapiro D.B. The potential of Angeli's salt to decrease nitric oxide scavenging by plasma hemoglobin. Free Radic. Biol. Med. 44 (2008) 1420-1432
40. Schrammel A., Behrends S., Schmidt K., Koesling D., and Mayer B. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol. 50 (1996) 1-5
41. Stoecklin G., Mayo T., and Anderson P. ARE-mRNA degradation requires the 5′-3′ decay pathway. EMBO Rep. 7 (2006) 72-77
42. Lasa M., Mahtani K.R., Finch A., Brewer G., Saklatvala J., and Clark A.R. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 20 (2000) 4265-4274
43. Dean J.L., Sarsfield S.J., Tsounakou E., and Saklatvala J. p38 Mitogen-activated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation. J. Biol. Chem. 278 (2003) 39470-39476
44. Ma P., Cui X., Wang S., Zhang J., Nishanian E.V., Wang W., Wesley R.A., and Danner R.L. Nitric oxide post-transcriptionally up-regulates LPS-induced IL-8 expression through p38 MAPK activation. J. Leukoc. Biol. 76 (2004) 278-287
45. Chae H.J., Chae S.W., Chin H.Y., Bang B.G., Cho S.B., Han K.S., Kim S.C., Tae K.C., Lee K.H., Kim D.E., Im M.K., Lee S.J., Chang J.Y., Lee Y.M., Kim H.M., Kim H.H., Lee Z.H., and Kim H.R. The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts. Bone 28 (2001) 45-53
46. Patil C., Zhu X., Rossa Jr. C., Kim Y.J., and Kirkwood K.L. p38 MAPK regulates IL-1beta induced IL-6 expression through mRNA stability in osteoblasts. Immunol. Invest. 33 (2004) 213-233
47. Lu-Kuo J.M., Austen K.F., and Katz H.R. Post-transcriptional stabilization by interleukin-1beta of interleukin-6 mRNA induced by c-kit ligand and interleukin-10 in mouse bone marrow-derived mast cells. J. Biol. Chem. 271 (1996) 22169-22174
48. Gilchrist M., and Befus A.D. Interferon-gamma regulates chemokine expression and release in the human mast cell line HMC1: role of nitric oxide. Immunology 123 (2008) 209-217
49. Xu L., Han C., Lim K., and Wu T. Activation of cytosolic phospholipase A2alpha through nitric oxide-induced S-nitrosylation: involvement of inducible nitric oxide synthase and cyclooxygenase-2. J. Biol. Chem. 283 (2007) 3077-3087
50. Swindle E.J., Metcalfe D.D., and Coleman J.W. Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. J. Biol. Chem. 279 (2004) 48751-48759
51. Zaman K., Hanigan M.H., Smith A., Vaughan J., Macdonald T., Jones D.R., Hunt J.F., and Gaston B. Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells. Am. J. Respir. Cell. Mol. Biol. 34 (2006) 387-393
52. Kubes P., Kanwar S., Niu X.F., and Gaboury J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7 (1993) 1293-1299
53. Selemidis S., Dusting G.J., Peshavariya H., Kemp-Harper B.K., and Drummond G.R. Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc. Res. 75 (2007) 349-358
54. Wang S., Yan L., Wesley R.A., and Danner R.L. Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP. J. Biol. Chem. 272 (1997) 5959-5965
55. Ptasinska A., Wang S., Zhang J., Wesley R.A., and Danner R.L. Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway. FASEB J. 21 (2007) 950-961
56. Wang S., Zhang J., Theel S., Barb J.J., Munson P.J., and Danner R.L. Nitric oxide activation of Erk1/2 regulates the stability and translation of mRNA transcripts containing CU-rich elements. Nucleic Acids Res. 34 (2006) 3044-3056
57. Tsatsanis C., Androulidaki A., Venihaki M., and Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38 (2006) 1654-1661
58. Muhl H., Chang J.H., Huwiler A., Bosmann M., Paulukat J., Ninic R., Nold M., Hellmuth M., and Pfeilschifter J. Nitric oxide augments release of chemokines from monocytic U937 cells: modulation by anti-inflammatory pathways. Free Radic. Biol. Med. 29 (2000) 969-980
59. Dean J.L., Sully G., Clark A.R., and Saklatvala J. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 16 (2004) 1113-1121
60. Briata P., Forcales S.V., Ponassi M., Corte G., Chen C.Y., Karin M., Puri P.L., and Gherzi R. p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol. Cell 20 (2005) 891-903
61. Hitti E., Iakovleva T., Brook M., Deppenmeier S., Gruber A.D., Radzioch D., Clark A.R., Blackshear P.J., Kotlyarov A., and Gaestel M. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell. Biol. 26 (2006) 2399-2407
62. Degousee N., Martindale J., Stefanski E., Cieslak M., Lindsay T.F., Fish J.E., Marsden P.A., Thuerauf D.J., Glembotski C.C., and Rubin B.B. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo. Circ. Res. 92 (2003) 757-764
63. Stoecklin G., Stoeckle P., Lu M., Muehlemann O., and Moroni C. Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. RNA 7 (2001) 1578-1588
64. Bonfield T.L., Panuska J.R., Konstan M.W., Hilliard K.A., Hilliard J.B., Ghnaim H., and Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am. J. Respir. Crit. Care Med. 152 (1995) 2111-2118
65. Borish L., Aarons A., Rumbyrt J., Cvietusa P., Negri J., and Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. 97 (1996) 1288-1296
66. Filippi C.M., and von Herrath M.G. IL-10 and the resolution of infections. J. Pathol. 214 (2008) 224-230
67. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., and Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5 (1999) 698-701
68. Rajakariar R., Hilliard M., Lawrence T., Trivedi S., Colville-Nash P., Bellingan G., Fitzgerald D., Yaqoob M.M., and Gilroy D.W. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc. Natl. Acad. Sci. USA 104 (2007) 20979-20984
69. Newlands G.F., Lammas D.A., Huntley J.F., MacKellar A., Wakelin D., and Miller H.R. Heterogeneity of murine bone marrow-derived mast cells: analysis of their proteinase content. Immunology 72 (1991) 434-439
70. Nakano T., Sonoda T., Hayashi C., Yamatodani A., Kanayama Y., Yamamura T., Asai H., Yonezawa T., Kitamura Y., and Galli S.J. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162 (1985) 1025-1043
71. Wolters P.J., Mallen-St Clair J., Lewis C.C., Villalta S.A., Baluk P., Erle D.J., and Caughey G.H. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin. Exp. Allergy 35 (2005) 82-88
72. Razin E., Ihle J.N., Seldin D., Mencia-Huerta J.M., Katz H.R., LeBlanc P.A., Hein A., Caulfield J.P., Austen K.F., and Stevens R.L. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 132 (1984) 1479-1486